Macro policy and crypto narratives are now central to any pepe price prediction for 2026. Federal Reserve guidance, sticky inflation readings, and institutional access via exchanges such as Coinbase and Grayscale change the risk budget for retail and professional allocators.
Investors demand an increase in capital gains exemption to ₹2 Lakh and the revival of Sovereign Gold Bonds as tax-efficient wealth tools
Kara Tsuboi covers today's top tech stories. Adjust your smart TV so it doesn't record your viewing data. Make long wait times more manageable with the iPhone's Call Assist feature. Invest in a light box to beat the winter blues.
Import taxes on Scotch whisky will be halved from 10% to 5% - a deal the UK government said would be worth £250m to the UK's economy.
Y Intercept Hong Kong Ltd decreased its holdings in shares of VNET Group, Inc. – Unsponsored ADR (NASDAQ:VNET – Free Report) by 54.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 178,808 shares of the information technology services provider’s stock after selling [...]
Commentary: This phone packs some key camera upgrades that make it a contender for one of 2026's best camera phones.
Higher-income earners are exhibiting 'seemingly cautious behaviour' on spending unlike their U.S. counterparts
Trump has nominated former Fed governor Kevin Warsh to lead the central bank, a move that could signal a shift towards closer White House influence over monetary policy.
St. George claimed the No. 1 spot in the annual "best performing cities" list from the Milken Institute. Here's why the booming southern Utah city took home top honors this year.
January 2026 saw major blockchain networks quietly advance infrastructure, scaling, and institutional integration, signaling a year focused on consolidation and practical growth rather than hype.The post One Month Into 2026: Ethereum Tunes Scaling, BNB Goes Sub-Second, And Avalanche Tokenizes Credit appeared first on Metaverse Post.
PARAMUS, NJ, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics (“Polaryx” or the “Company”) a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), today announced that shares of the Company’s common stock have been approved for listing on the Nasdaq Capital Market (“Nasdaq”) under the ticker symbol “PLYX”. Shares of Polaryx common stock are expected to commence trading on or about February 2, 2026.
GREENWICH, Conn., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (NasdaqGS: OXLCG) (“Oxford Lane,” the “Company,” “we,” “us” or “our”) announced today the following financial results and related information: